Skip to main content

Table 1. Patients’ characteristics

From: Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis: an exploratory study

Characteristics Patients (n = 11)
Age, years, mean (range) 64 (57–72)
Male sex, n (%) 7 (63.6)
Etiology of cirrhosis
 Alcohol, n (%) 9 (81.8)
 NASH, n (%) 1 (9.1)
 Other, n (%) 1 (9.1)
Severity and complication of cirrhosis
 MELD-score 20 (± 9)
 Child Pugh B, n (%) 3 (27.3)
 Child Pugh C, n (%) 8 (72.7)
 Esophageal varices, n (%) 5 (45.5)
 Prior gastrointestinal bleeding, n (%) 3 (27.3)
 Prior hepatic encephalopathy n (%) 1 (9.1)
 Prior hepatorenal syndrome, n (%) 1 (9.1)
 Primary SBP prophylaxis, n (%) 6 (54.5)
Fluoroquinolones used for prophylaxis
 Norfloxacin, n (%) 8 (72.7)
 Ciprofloxacin, n (%) 3 (27.3)
Concomitant medication
 Beta-blocker, n (%) 6 (54.5)
 Proton-pump inhibitors, n (%) 7 (63.6)
Laboratory results
 C-reactive protein (mg/dL) 2.9 (± 2.7)
 White blood count (/nL) 7.8 (± 3.0)
 Bilirubin (mg/dL) 5.9 (± 6.5)
 Alanine aminotransferase (U/L) 40 (± 37)
 International normalized ratio 1.8 (± 0.5)
 Creatinine (mg/dL) 1.5 (± 0.9)
 Albumin (g/dL) 3.2 (± 1.5)